Log in
Enquire now
MedScience Ventures

MedScience Ventures

MedScience Ventures or MSV is a fund management company in Boston focused on life science and medical technologies.

OverviewStructured DataIssuesContributors

Contents

medscienceventures.com
Is a
Organization
Organization
Investor
Investor
Venture capital firm
Venture capital firm
Company
Company

Company attributes

Location
Boston
Boston
B2X
B2B
B2B
0
Pitchbook URL
pitchbook.com/profiles...170309-89
Number of Employees (Ranges)
11 – 500
Founded Date
2016

Venture Capital Firm attributes

Invested in
Biodirection
Biodirection
Yofumo Technologies
Yofumo Technologies

Other attributes

Company Operating Status
Active

MedScience Ventures is a venture capital firm in Boston that invest in the life science and medical technologies sectors. Founded 2016 in Boston, Massachusetts, United States, the firm usually invests in early stage ventures. Its portfolio companies include Yofumo Technologies and Biodirection. As of February 2020, MedScience Ventures has made two investments. Their most recent investment was on Jun 13, 2017, when Yofumo Technologies raised $1.5M. It seeks to partner with early-stage companies to provide consulting services, obtain license rights in specific markets and evaluate making equity investments.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Associated Investment Funds

Accelerator Batches

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like MedScience Ventures

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.